Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648)

被引：310

作者：

Aiello, Stefania ^{[1
,2
]}

Wells, Geoffrey ^{[3
]}

Stone, Erica L. ^{[4
]}

Kadri, Hachemi ^{[1
]}

Bazzi, Rana ^{[5
]}

Bell, David R. ^{[5
]}

Stevens, Malcolm F. G. ^{[3
,4
]}

Matthews, Charles S. ^{[4
]}

Bradshaw, Tracey D. ^{[4
]}

Westwell, Andrew D. ^{[1
]}

机构：

[1] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3NB, S Glam, Wales

[2] Univ Palermo, Fac Farm, Dipartimento Farmacochim Tossicolog & Biol, I-90123 Palermo, Italy

[3] Pharminox Ltd, Nottingham NG1 1GF, England

[4] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England

[5] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2008年 / 51卷 / 16期

关键词：

D O I：

10.1021/jm800418z

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

New fluorinated 2-aryl-benzothiazoles, -benzoxazoles, and -chromen-4-ones have been synthesized and their activity against MCF-7 and MDA 468 breast cancer cell lines compared with the potent antitumor benzothiazole 5. Analogues such as 9a,b and 12a,d yielded submicromolar GI(50) values in both cell lines; however, none Of the new compounds approached 5 in terms of antitumor potency. For 5, binding to the aryl hydrocarbon receptor appeared to be necessary but not sufficient for growth inhibition.

引用

页码：5135 / 5139

页数：5

共 24 条

[1] The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate
Bradshaw, TD
Westwell, AD
[J]. CURRENT MEDICINAL CHEMISTRY, 2004, 11 (08) : 1009 - 1021
[2] Mechanisms of acquired resistance to 2-(4-Amino-3-methylphenyl)benzothiazole in breast cancer cell lines
Bradshaw, Tracey D.
Stone, Erica L.
Trapani, Valentina
Leong, Chee-Onn
Matthews, Charles S.
Poele, Robert te
Stevens, Malcolm F. G.
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 110 (01) : 57 - 68
[3] Fluorinated 2-(4-amino-3-methylphenyl) benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells
Brantley, E
Trapani, V
Alley, MC
Hose, CD
Bradshaw, TD
Stevens, MFG
Sausville, EA
Stinson, SF
[J]. DRUG METABOLISM AND DISPOSITION, 2004, 32 (12) : 1392 - 1401
[4] Chua MS, 2000, CANCER RES, V60, P5196
[5] Parallel synthesis of a library of benzoxazoles and benzothiazoles using ligand-accelerated copper-catalyzed cyclizations of ortho-halobenzanilides
Evindar, G
Batey, RA
[J]. JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (05) : 1802 - 1808
[6] The experimental antitumor agents Phortress and Doxorubicin are equiactive against human-derived breast carcinoma xenograft models
Fichtner, I
Monks, A
Hose, C
Stevens, MFG
Bradshaw, TD
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 87 (01) : 97 - 107
[7] Relationship between aryl hydrocarbon receptor-affinity and the induction of EROD activity by 2,3,7,8-tetrachlorinated phenothiazine and derivatives
Fried, Kristian W.
Bazzi, Rana
Lopez, Walkiria Levy
Corsten, Claudia
Schramm, Karl-Werner
Bell, David R.
Rozman, Karl K.
[J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 224 (02) : 147 - 155
[8] Metabolically stabilized benzothiazoles for imaging of amyloid plaques
Henriksen, Gjermund
Hauser, Andrea I.
Westwell, Andrew D.
Yousefi, Behrooz H.
Schwaiger, Markus
Drzezga, Alexander
Wester, Hans-Juergen
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (06) : 1087 - 1089
[9] Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs
Hutchinson, I
Jennings, SA
Vishnuvajjala, BR
Westwell, AD
Stevens, MFG
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (03) : 744 - 747
[10] Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles
Hutchinson, I
Chua, MS
Browne, HL
Trapani, V
Bradshaw, TD
Westwell, AD
Stevens, MFG
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (09) : 1446 - 1455

← 1 2 3 →